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ABSTRACT 
Sterile preparations for intravenous injection probably cause greater risk of errors than other 
preparation treatment routes due to their complex preparation steps. Errors in preparation and 
compounding stage will affect the quality and stability of the pharmaceutical product obtained. The aim of 
this study was to evaluate the process of compounding and assess both quality and stability of the 
parenteral preparations products that resulted from the compounding process for ICU’s patients in one 
private hospital in Semarang, Central Java, Indonesia. This observational analytic study was conducted 
using accidental sampling technique. The descriptive study results showed that sterile preparation in 
hospital “X” was not performed according to the Guidelines for Drug Injection and Handling of Cytostatic 
Preparations. In order to evaluate the quality of the sterile preparations, three different drugs with the 
highest prevalence of use: namely ceftriaxone, meropenem and omeprazole were evaluated. It was found 
that the pH value of omeprazole was not acceptable due to the use of an appropriateness solvent. The 
sterility tests showed that the preparation products prepared by the nurses were free from microorganisms. 
Keywords: dispensing errors, intensive care unit, intravenous preparations, patient, sterile compounding 
 
ABSTRAK 
Pemberian obat secara intravena memiliki resiko kesalahan yang lebih besar dibandingkan dengan 
rute pengobatan lain karena tahap preparasi dan peracikan yang lebih kompleks. Kesalahan pada 
preparasi dan peracikan akan berpengaruh pada kualitas hingga stabilitas sediaan parenteral yang 
diracik. Tujuan dari penelitian ini adalah mengevaluasi proses peracikan, kualitas serta stabilitas sediaan 
parenteral yang dihasilkan dari proses peracikan untuk pasien Intensive Care Unit (ICU) salah satu 
rumah sakit swasta (RS “X”) di Semarang. Penelitian ini merupakan penelitian observasional analitik 
dengan teknik pengambilan data secara accidental sampling. Subyek penelitian terbagi menjadi dua 
macam yaitu subyek penelitian deskriptif dan subyek penelitian analitik. Hasil deskriptif menunjukan 
preparasi hingga peracikan yang dilakukan di ICU RS “X” belum dilakukan sesuai Pedoman 
Pencampuran Obat Suntik dan Penanganan Sediaan Sitostatik. Kualitas sediaan racikan yang dievaluasi 
adalah tiga macam obat dengan prevalensi penggunaan tertinggi yakni; ceftriaxone, meropenem dan 
omeprazole. Pengujian menunjukan terdapat perbedaan nilai pH sediaan injeksi omeprazol yang diracik 
di rumah sakit karena penggunaan pelarut yang tidak tepat. Hasil uji bebas kuman menunjukkan pada 
sediaan yang diracik tidak terdapat pertumbuhan mikroorgannisme. 
Kata kunci: dispensing error, intensive care unit, sediaan parenteral, pasien, peracikan sediaan steril 
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INTRODUCTION 
Parenteral preparations are described as 
preparations intended for injection, infusion or 
implants in the body. Parenteral administration has 
several benefits such as its fast onset and effect, 
avoiding the first pass effect, predictability of drug 
amount in the blood, avoiding the drug 
degradation in the gastrointestinal system, and its 
possibility to treat an emergency and unconscious 
patients (Shargel et al., 2005). 
It is should be considered that parenteral 
administration of drugs may have higher risk of 
medication errors compared to other 
administration routes. The complex steps during 
preparation, compounding, storage, and 
administration lead to the possibility of medication 
errors. Several drugs which are unstable in the 
form of solution need to be reconstituted before 
administration due to their solid form. Dose 
adjustment should be done for several drugs to 
provide specific medication dose for patients. The 
possibility of medication errors is becoming more 
important since the stricter requirement of drug 
carriers and the toxicity issues for several 
parenteral administration drugs (Agoes, 2009). 
According to the Indonesian Ministry of 
Health (2009; 2009) sterile preparations 
compounding should be done by pharmacists at 
the Pharmacy Installation. Sterile preparations 
compounding requires special techniques with a 
background in knowledge of sterility, 
physicochemical properties, drug stability, drug 
incompatibility and the risk of dangerous exposure 
to drugs such as for antibiotics (Nguyen et al., 
2015). In addition, special facilities and 
infrastructure are needed to support the whole 
compounding work to achieve the sterility and 
drug stability. 
Previous studies have been conducted to 
evaluate the compounding process of sterile 
preparations compared to the Guideline for I.V. 
Admixture and Handling Cytostatic and Basic 
Guidelines of Sterile Dispensing (Ministry of 
Health of the Republic of Indonesia, 2009; 
Ministry of Health of the Republic of Indonesia., 
2009). The studies showed that some critical 
aspects in sterile preparations did not meet the 
requirements according to the guidelines, such as 
personnel, facilities, infrastructures and aseptic 
process (Putri and Yuliani, 2018; Sudianto et al., 
2018). 
Previous research in order to assess the 
compatibility of intravenous drugs for ICU 
patients has been conducted in a hospital in 
Surabaya. The results showed that 30.16% of 
sterile preparations compounding were done 
without considering the compatibility of the drug 
compounded (Dwijayanti et al., 2016). Research 
related to compatibility evaluation also concluded 
that incompatibility of sterile preparations was one 
of the real problems that occurred in patients’ 
medication in the ICU. The percentage of 
occurrences for incompatibility incidents were 
reported in the range of 0.30% to 18.70% (Fahimi 
et al., 2008). A systematic review study conducted 
by Salmasi et al. (2015) found that the common 
errors that occur during preparation handled by 
pharmacists and nurses in Malaysia and Vietnam 
were wrong techniques and wrong solvent types. A 
study conducted by Ong and Subasyimi (2013) at 
Selayang Hospital Malaysia showed that there 
were 341 errors identified from 349 preparations 
and administration stages. Research conducted by 
Strbova et al. (2015) found that unclear drug labels 
increase the risk of medication errors. Hence, it is 
necessary to assess the conformity of the 
procedures for parenteral preparations 
compounding. 
Research related to the compounding of 
sterile preparations in the ICU has never been done 
at the hospital where the data was collected. The 
aim of this study was to evaluate the compounding 
process as well as assess the quality and stability 
of the parenteral preparations for ICU’s patient in 
one of the private hospitals in Semarang, Cental 
Java, Indonesia. The results from this study will be 
useful in order to improve the pharmaceutical care 
implementation in the hospital.  
 
METHODS 
Study design 
This research was a non-experimental study 
with descriptive and analytical design conducted 
by observing prospectively a type C private 
hospital in Semarang with the research permission 
number of 748.2/RSX/LP/DIKLAT/ VIII/2017. 
Data collection was done every Saturday and 
Sunday during September to October 2017 with 
accidental sampling technique. The independent 
variables in the descriptive study were the 
personnel, compounding process, and the results of 
sterile preparations, while the dependent variables 
were the conformity according to the Guideline for 
I.V. Admixture and Handling Cytostatic (Ministry 
of Health of the Republic of Indonesia., 2009). 
Analytical study was conducted at the 
Pharmacy Laboratory of Universitas Sanata 
Dharma in October 2017 with a purposive 
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sampling technique. The independent variable in 
this study was the process of compounding the 
preparation, while the dependent variables were 
pH and the presence or absence of microbial 
growth. 
 
Instrumentations 
The research instrument used in this 
descriptive study was a set of observational sheets 
according to the Guideline for I.V. Admixture and 
Handling Cytostatic and Basic Guidelines of 
Sterile Dispensing (Ministry of Health of the 
Republic of Indonesia, 2009). The instrument used 
for analytic study was a pH meter. 
The observational sheet includes several 
aspects as follows: 1) facilities, infrastructure and 
supporting system (including compounding 
personnel, compounded sterile rooms, laminar air 
flow, pass boxes, special waste bags); 2) 
compounding preliminaries (including right 
patient, right medication, right dosage, right route, 
right administration time, checking the drug name, 
checking product expiration date, checking 
product batch number, accuracy of solvent / 
diluent, accuracy of the amount of solvent); 3) 
compounding process (including washing hands 
before compounding work, use gloves and masks, 
hand disinfection, ampule/vial disinfection before 
opened, sample transfer techniques, use of single-
use needles); and 4) results of sterile preparations 
(clarity, stability, labelling, complete information 
on label). 
  
Observation 
Observation data were collected by observing 
the preparation process and compounding process 
of sterile preparations. The inclusion criteria of the 
study subjects were compounding parenteral 
preparations for the "X" Hospital ICU patients 
done during the observation period. All samples 
that met the inclusion criteria for conformity were 
immediately evaluated for compounding errors 
during the compounding preliminaries and process 
of parenteral preparations according to the 
guidelines. In this study, there were no exclusion 
criteria because all existing samples were 
evaluated.  
 
Test of Sterile Preparation Quality 
Quality evaluation of sterile preparations was 
done on all samples which met the inclusion 
criteria. The inclusion criteria were defined as the 
three drugs with the highest frequency of use for 
ICU patients in Hospital "X" based on 
observations. The three drugs were formulated 
twice (duplo); one sample was formulated based 
on the compounding procedure in the hospital with 
the worst case condition (worst case criteria based 
on observations), while one other sample was 
formulated according to the Guideline for I.V. 
Admixture and Handling Cytostatic and Basic 
Guidelines of Sterile Dispensing (Ministry of 
Health of the Republic of Indonesia, 2009). 
Analytical data collection was done by measuring 
the pH suitability using a pH meter. The germ-free 
test was done at the Semarang Health Center by 
inoculating samples of sterile preparation into a 
universal medium for bacteria, then observing the 
presence or absence of microbial growth. 
 
Data analysis 
Data analysis was done by verifying the 
observations listed in the Observational Sheet with 
the reference literature used, Guideline for I.V. 
Admixture and Handling Cytostatic and Basic 
Guidelines of Sterile Dispensing. Analysis of 
observation data was done by calculating the 
percentage form of errors in each aspect using the 
equation:  
 
……………..(1) 
If the result for % nonconformity is 0%, it can be 
concluded that the aspect in compounding 
preliminaries and process was meeting the 
requirements as mentioned in the Guideline for 
I.V. Admixture and Handling Cytostatic and Basic 
Guidelines of Sterile Dispensing. 
 
RESULTS AND DISCUSSION 
Observations were conducted for 25 patients 
in ICU consisting of 24 adult patients and 1 
pediatric patient. During the observation, 119 
sterile preparations were provided (Figure 1). The 
results showed that sterile preparations with 
highest frequently prepared were omeprazole 
injection, meropenem injection, and ceftriaxone 
injections. 
Critically-ill patients have high potential of 
getting stress-related mucosal disease (SRMD). 
Omeprazole is a proton pump inhibitor (PPI). It is 
an effective agent to decrease gastric acid 
secretion. Omeprazole is often used with critically 
ill patients because it is more effective than 
histamine 2 receptor antagonists in preventing 
clinically important and overt upper 
gastrointestinal bleeding (Alhazzani et al., 2013; 
Barkun et al., 2012). It can explain why 
omeprazole injection was the most frequently 
prepared in ICU. 
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Figure 1. Sterile preparation during observation 
 
Infections are common in patients in 
contemporary ICUs, and risk of infection increases 
with duration of ICU stay so that they get 
antibiotics (Vincent et al., 2009). Meropenem and 
Ceftriaxone are in the family of β-lactam type of 
antibiotics. Both are frequently used in ICUs for 
severe infection or to prevent another infection 
(Wong et al., 2014). Ceftriaxone is a well tolerated 
third generation cephalosporin with a broad 
spectrum activity against gram positive and gram 
negative bacteria, commonly used in intensive care 
units (ICU) for the empirical or documented 
treatment of a wide range of infections, such as 
pulmonary, urinary, intra abdominal and central 
nervous system infections (Garot et al., 2011). 
Meropenem has a good potential to prevent 
nosocomial infection from becoming worse and as 
therapy for bacteremia conditions (Trisnadewi and 
Widodo, 2014). It also explains why these two 
antibiotics were commonly used for ICU patients. 
 
Facilities, Infrastructure and Supporting 
System 
The observation results for Facilities, 
Infrastructure and Supporting System are shown in 
Table I. Regulations in Indonesia state that 
compounding of sterile preparations is under the 
responsibility of a certified pharmacist in the 
Hospital(Ministry of Health of the Republic of 
Indonesia, 2016; Ministry of Health of the 
Republic of Indonesia., 2009; Ministry of Health 
of the Republic of Indonesia, 2009; Webster, 
2015). Compounding of sterile preparations for 
ICU patients in Hospital X were done by nurses. 
The lack of the pharmacist's role in compounding 
sterile preparations in the ICU is due to the limited 
number of pharmacists with overloaded duty for 
pharmacy service in the hospital.  
The process of preliminaries and 
compounding of sterile preparations must be done 
by personnel/staff who have been trained under the 
responsibility and supervision of pharmacists in 
Hospital Pharmacy Installation because 
Pharmacists have the knowledge and skills in 
dispensing drugs, both in terms of mixing 
techniques, related to aspects of sterility, and to the 
stability aspects of the sterile preparation. If indeed 
compounding cannot be done by pharmacists, then 
the short-term solution that can be done is by 
increasing the capacity of personnel in the field of 
sterile preparations as continuing education 
activities for hospital health workers to improve 
patient services as a form of Pharmaceutical Care 
and Interprofessional Education (Maharani et al., 
2013; Putri and Yuliani, 2018).  
Facilities and infrastructure for compounding 
sterile preparations in the ICU of Hospital “X” did 
not conform to the guidelines. In the Hospital "X" 
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compounding parenteral preparations for ICU 
patients were done in the ward, where there were 
no sterile rooms or special equipment to support 
the compounding process. The nurse performs a 
compounding process on the table that is used to 
mix parenteral and non-parenteral preparations. 
Before compounding sterile preparation, the nurses 
have to make sure that table is clean and there are 
no ingredients other than those used for 
compounding. The table is placed in the nurse's 
room next to the administration desk and doctor's 
table. The compounding process is carried out 
without Laminar Air Flow (LAF), without 
completing the compounding document and does 
not include medical devices used for 
compounding, labeling, and drugs that will be 
mixed or compounded into a sterile space through 
a pass box.  
Based on the Basic Guidelines for Dispensing 
Sterile Preparations, compounding sterile 
preparations should be done in a sterile room, in 
LAF. All tools and material that are needed should 
be taken to a sterile room via a pass box. If there 
are no sterile room facilities and LAF, the short-
term solution for compounding parenteral 
preparations can be carried out in special 
conditions by paying attention to various aspects 
such as the compounding space used must be 
clean, separate and special for sterile preparations 
only because the procedure performed must be 
aseptic. Special tables that are routinely cleaned 
and sterilized can be used instead of LAF for short 
term solutions.  
 
Table I. Results of the descriptive study on several aspects (n= 119) 
Aspects 
Nonconformity 
(%) 
Facilities, infrastructure and supporting system  
Conducted by pharmacist 100.00 
Sterile room availability 100.00 
LAF availability 100.00 
Pass box availability 100.00 
Special waste bag availability 0 
Compounding preliminaries  
Right patient, right medication, right dosage, right route, right 
administration time 
0 
Checking the drug name 0 
Checking product expiration date 0 
Checking product batch number 100.00 
Appropriateness of solvent 25.21 
Solvent volume accuracy  32.77 
Compounding process  
Washing hands before compounding work 33.00 
Usage of gloves and masks 100.00 
Hand disinfection 0 
Ampule/vial disinfection before opened 31.09 
Sample transfer techniques 0 
Usage of single-use needles 0 
Result of sterile preparations  
Clarity 10.08 
Stability  2.52 
Labelling 0 
Complete information on label 0 
 
Table II. pH evaluation of sterile preparation 
No. Sterile preparation Theoretical pH pH sample A pH sample B 
1. Ceftriaxone 1 gram 6-8 6.5 6.4 
2. Meropenem 1 gram 7.3-8.3 7.5 7.7 
3. Omeprazole 40 mg 8.8-10 8.3 8.6 
Note: 
Sample A is sterile preparation compounded in Hospital X with worst case 
Sample B is sterile preparation compounded based on Basic Guidance of Sterile Dispensing 
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Special waste bags for sterile preparations are 
needed to prevent accident. Sterile preparation 
involving the use of syringes and ampules are 
categorized as risk or hazardous waste (Amin et 
al., 2013; Chartier, 2014). All of the sterile 
preparation waste in ICU Hospital X have been 
separated from general waste. There were some 
special bags to collect the hazardous waste. 
 
Compounding preliminaries 
Compounding preliminaries involve a 
number of activities, including checking that the 
patient’s name, drug, dosage, route and 
administration time is correct, product’s expired 
date, and product’s batch number. Other important 
steps to do are calculating dosage suitability, using 
appropriate solvents, calculating solvent volume, 
making labels and completing compounding 
documents to prevent medication errors that can 
harm patients (Cousins et al., 2005). 
Conformity profile of preliminaries phase 
before compounding sterile preparations in ICU in 
Hospital X is shown in Table I. Personnel who 
performed preliminaries had checked the patient, 
medications, dosage, route, administration time, 
and product’s expired date before they 
compounded. This is a good practice that must be 
maintained to reduce the risk of medication errors. 
Meanwhile, the batch number of the drug were not 
checked even once. The batch number of the 
product must be observed and recorded in the 
compounding document as an archive, so that if 
one day medication error is found that arose in the 
preparation caused by the initial product it can be 
traced and reported to the manufacturer (Collins, 
2014).  
A total of 25.21% of drugs were done using 
appropriateness solvents (compared with solvent 
in Handbook of Injectable Drugs). In ICU Hospital 
X, most of the sterile preparations (Figure 1) were 
formulated or reconstituted with Aqua Pro 
Injection and given through a syringe pump, 
except ketorolac and tramadol preparations that 
were using 0.9% NaCl as a solvent and given by 
i.v. drip. There are limited information about 
incompatibility of some product with several 
solvents (Dwijayanti et al., 2016; Kanji et al., 
2010). This gap becomes a difficulty in assessing 
the potential incompatibility of a drug with a 
solvent. The safest way that can be done is to use 
solvents that have been known to be compatible 
with the drug based on several trusted literature 
such as the current Handbook of Injectable Drugs 
(FASHP, 2012).  
A total of 32.77% of drugs were dissolved 
with inaccuracies in volume of solvent (compared 
with volume suggested in brochure).  The main 
guideline used to see the volume of drug solvents 
is the drug packaging leaflet. If there is no 
information how much the volume of solvents 
recommended in the drug packaging leaflet, the 
researchers recommend other guidelines such as 
the Handbook on Injectable Drugs 16th Edition 
(FASHP, 2012) or the Guideline for I.V. 
Admixture and Handling Cytostatic (Ministry of 
Health of the Republic of Indonesia., 2009).  
An example of the inaccuracy volume of 
solvent that was observed is the compounding of 
ceftriaxone injection. The leaflet states that each 1 
gram of ceftriaxone powder for injection is 
dissolved with 10 mL of water for injection. At the 
time of observation, ceftriaxone reconstitution was 
done with a variety of solvent volumes: 5 mL, 8 
mL; up to 20 mL. The difference in the amount of 
solvent can affect the solubility rate of ceftriaxone 
injection in solvents and the tonicity of the 
solution (Putri and Yuliani, 2018). 
 
Compounding Process 
The observation results show that some 
aseptic techniques were not implemented well in 
ICU Hospital X (Table I). Implementation of 
aseptic techniques must be carried out in 
compounding sterile preparations. One procedure 
that must be done in aseptic techniques before 
compound preparations is personnel must wear a 
complete personal protective equipment (PPE), 
which is done to prevent possibilities of 
contamination from personnel to preparations that 
are formulated and also prevent exposure to the 
drugs formulated to personnel. In addition, hand 
washing or hand disinfection is a mandatory 
activity to fulfill aseptic procedures (Ministry of 
Health of the Republic of Indonesia, 2009) 
Surprisingly, all of the compounding sterile 
preparations (100%) observed were performed 
without wearing handscoon and mask while 33% 
did not involve washing hands, although at least 
they have disinfected hands before compounding 
the sterile preparations.  
If compounding were not done aseptically, it 
is likely that contamination will occur and can 
threaten patients’ safety and cause medication 
errors (Agyemang and While, 2010). Factors that 
can cause nurses to not follow the procedure of 
aseptic techniques are high workloads or the low 
ability or lack of knowledge about basic guidelines 
in compounding sterile preparations (Keers et al., 
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2015). One short-term solution that can be done is 
by conducting training on good compounding 
sterile preparations (aseptic technique), in order to 
improve the ability of (Maharani et al., 2013).  
Aseptic techniques should be implemented to 
reduce risk of contamination. Right transfer 
technique and using single needle/syringe to 
collect the drug can optimize this important goal 
(Ministry of Health of the Republic of Indonesia, 
2009). All compounding sterile preparations in 
ICU Hospital X were performed with a good 
transfer technique and always uses single 
needle/syringe. 
 
Results of sterile preparations 
The observation results of sterile preparations 
are shown in Table I. We found that 10.08% of 
sterile preparations had turbidity after being 
compounded and then a few moments later 
turbidity disappeared. It happened in ceftriaxone 
injections dissolved with 5 mL. However, turbidity 
indicates the presence of powdered drug particles 
that are still visible in the solution. It can become 
harmful to the patients because it can cause 
embolism if it has not been completely dissolved 
when administered (Langille, 2013).  
The stability of sterile preparations must also 
be a concern. Stability of stocks includes physical, 
chemical, and microbiological stability. Changes 
in physical stability can be identified if there is a 
change in color, appearance, clarity, and 
consistency of the preparation. Changes in 
chemical stability are indicated by product 
degradation. There are several factors that affect 
product degradation, such as light, metal, oxygen, 
water, etc.  (Falconer and Steadman, 2017; 
Srivastava and Kumar, 2017).  
The results of the observation showed that 
there was potential for instability that might occur 
as much as 2.52% in nicardipine injection 
preparations. According to (FASHP, 2012) 
nicardipin injection is one of the photosensitive 
drugs, but in ICU Hospital X, nicardipin injections 
were not protected from light, while in the storage 
instructions printed on the label, it states it must be 
kept away from direct light. The possibility that 
can occur if photosensitive preparations exposed to 
light is a decrease in stability. One short-term 
solution that possibly can be done according to the 
Guideline for I.V. Admixture and Handling 
Cytostatic (Ministry of Health of the Republic of 
Indonesia, 2009) is to protect the solution using 
aluminum foil or black bags to protect 
photosensitive drugs from light.  
Sterile preparations should be labelled after 
compounded. Right labelling can prevent 
medication error (Merali et al., 2008). In ICU 
Hospital X, the sterile preparation were not 
labelled after compounded, which means that there 
was no information about the products. The reason 
from the personnel is because the sterile 
preparations were directly administered to patients 
and the hospital did not provide labels for the 
sterile preparations.  
Standard labels for sterile preparations in 
Guideline for I.V. Admixture and Handling 
Cytostatic (Ministry of Health of the Republic of 
Indonesia, 2009) should contain important 
information such as: Patient’s name, medical 
report number, room, drug, concentration/dose, 
administration route, compounding date and time, 
beyond use date, storage procedure. One short 
term solution that can possibly be done is 
providing labels for sterile preparations. Pre-
printed or peel-off flag labels on ampules and vials 
can facilitate correct labelling (Merry et al., 2011). 
 
Physical quality of sterile preparations 
Physical quality tests were done on 3 drugs 
with the highest frequency of use, i.e. Ceftriaxone 
1 gram, Meropenem 1 gram and Omeprazole 40 
mg. Evaluations carried out included pH test and 
germ free test. Evaluation was done on sterile 
preparations compounded by following the Basic 
Guidance of Sterile Dispensing and sterile 
preparations compounded by the hospital based on 
the worst conditions observed, i.e. not using PPE, 
not washing hands, and done at the nurse's desk. 
An important component that must be 
considered in dispensing sterile preparations is the 
pH of the compounded drugs which will have an 
impact on incompatibility (Newton, 2009). The pH 
test was done on two groups of test subjects and 
the results are listed in Table II. Chemical 
incompatibility describes the chemical degradation 
of one or more drugs compounded, causing 
therapeutic toxicity or inactivation. Degradation is 
not always observable. Specific pH values or a 
narrow range of pH values are needed to maintain 
drug stability after being mixed (Newton, 2009).  
The pH of Sample A and Sample B for 
Ceftriaxone 1 gram and Meropenem 1 gram that 
was dissolved in water for injection, conformed 
with theoretical pH. Meanwhile pH of Sample A 
Omeprazole injection had a pH below theoretical 
pH. It possibly happened because omeprazole in 
ICU Hospital X was dissolved using water for 
injection instead of the appropriate solvent 
provided from the manufacturer. It is especially 
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important to always use the right solvent to get the 
right pH.  
A germ-free test was conducted on samples 
produced from compounding in the ICU Hospital 
"X". Sterile means that the preparation meets the 
criteria free of microorganisms, pathogens and 
particles. In this study, the researchers defined the 
term, sterile is to be free of germs or 
microorganisms and proved by testing in the 
laboratory of Semarang Health Center. The test 
results show that the preparations produced from 
Hospital X are germ-free. It might happen because 
two of the samples tested are antibiotics while the 
process of inoculating samples to universal media 
was done without inactivating the ability to inhibit 
bacteria. In addition, other factors that can be 
influential are the products might contain 
preservatives, so microorganisms cannot 
contaminate them (Pramanick et al., 2013). 
 
CONCLUSIONS 
Based on the research conducted, it can be 
concluded that the compounding process carried 
out for patients in the Intensive Care Unit "X" 
Hospital is largely not in accordance with the 
Guidelines for Compounding Syringes and 
Cytostatic Treatment. The quality of 3 sterile 
preparations was free of bacterial growth. The pH 
measured of Ceftriaxone and Meropenem was still 
in the pH range based on the literature. Meanwhile 
pH of Omeprazole injection that was dissolved 
using appropriateness solvent had a pH below 
theoretical pH. It is especially important to always 
implement The Guideline for I.V. Admixture and 
Handling Cytostatic and The Basic Guidelines of 
Sterile Dispensing to prevent medication errors 
that can harm the patient. 
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